Publications by authors named "A H Shahidi-Bonjar"
Electronic cigarette (EC) is widely advertised as a safe alternative to traditional cigarette (TC). We aimed to investigate the cardiovascular effect of EC with/without nicotine compared with TC. We systematically searched PubMed/MEDLINE, EMBASE, and Cochrane CENTRAL for randomized controlled trials that compared the effect of different smoking modalities on cardiovascular function up to 1 October 2024.
View Article and Find Full Text PDFIntroduction: Depression and anxiety are pervasive mental health disorders with substantial global burdens. Probiotics, live microorganisms known for their health benefits, have emerged as a potential therapeutic intervention for these conditions. This systematic review and meta-analysis aim to evaluate the strain-specific effects of probiotics on relieving depressive and anxiety symptoms while elucidating underlying mechanisms.
View Article and Find Full Text PDFIntroduction: This manuscript offers an in-depth comparative examination of the effectiveness of higher-dose (double standard-dose and high-dose) influenza vaccines in contrast to a single standard-dose vaccine when it comes to alleviating major cardiovascular events.
Study Design: Meta-Analysis.
Methods: To conduct this study, an exhaustive search was carried out in the medical English literature using databases such as PubMed/MEDLINE, EMBASE, and the Cochrane CENTRAL until 10 April 2024.
Article Synopsis
- Osteoporosis is a major health issue for people with chronic kidney disease (CKD), increasing fracture risks and complicating treatments, especially in advanced CKD stages 4 and 5.
- A review of 12 randomized controlled trials with over 31,000 participants found that certain anti-osteoporotic medications (like teriparatide and denosumab) significantly reduce vertebral fracture risk, although their effectiveness is less pronounced in stages 4 and 5 of CKD.
- The study shows romosozumab resulted in better improvements in bone mineral density (BMD) across all CKD stages, with no serious side effects reported for any of the treatments.
TB and interstitial lung disease: a systematic review and meta-analysis.
Int J Tuberc Lung Dis
March 2024